Light Mode
Dark Mode
System Mode
New analysis shows cocaine deaths now exceed heroin fatalities in England and Wales, prompting urgent public health and policy concern.
The number of deaths from cocaine use in England and Wales nearly quadrupled over the past decade and in 2025 cocaine was mentioned in more drug poisoning deaths than heroin or morphine, according to Office for National Statistics data. There were 5,519 drug poisoning deaths registered in 2025, equivalent to 92.4 deaths per million people, and cocaine was mentioned in 1,233 of those cases while heroin or morphine was mentioned in 1,210 cases.
The overall rate of drug deaths fell for the first time since 2012, decreasing from 93.9 deaths per million the previous year, though the ONS noted a lag can exist between deaths occurring and being registered. Despite the small overall decline, experts highlighted widening regional inequalities, with the rate more than twice as high in the North East as in London.
Deaths linked to opiate and opioid drugs combined remained higher than those linked to cocaine alone. Regional increases were steepest in formerly industrial areas with longstanding poverty and unemployment, including the North East, Wales, Yorkshire and the Humber, the North West and the East Midlands.
Ketamine was referenced in a record 115 deaths in 2025, almost double the number from 2024 and up from seven a decade earlier. Commentators attributed the rise to lower prices and the normalization of ketamine use, with reports of young people developing dependence and acute health problems such as bladder damage.
Experts and charity figures warned that increased purity and availability of cocaine and the proliferation of potent synthetic opioids, such as nitazenes, are raising risks for users. Nitazenes can be many times more potent than heroin and have been linked to hundreds of UK deaths. Families affected by recent deaths, including the siblings of Anthony Irvin who died from drug poisoning in Ramsgate in September 2025 at age 52, expressed concern about possible contamination of drug supplies with synthetic opioids and about delays in blood testing.
The data indicate a shifting profile of drug-related harm in England and Wales where cocaine has become a leading named contributor to fatal poisonings, reflecting changes in purity and availability. Although the overall death rate fell slightly, persistent regional disparities and the continuing dominance of opiates and opioids in combined figures show the epidemic remains severe and geographically uneven. The rapid rise in ketamine-linked deaths points to changing patterns of use and emerging health consequences among younger users. Combined with the spread of highly potent synthetic opioids such as nitazenes, these trends complicate response efforts and underscore the need for targeted public health interventions in the worst affected regions.